|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 401/14 | |
| A61K 31/506 | |||
| A61P 35/00 | |||
| A61P 31/12 |
| (11) | Patento numeris | 2903979 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13843995.5 |
| Europos patento paraiškos padavimo data | 2013-10-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-08-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/063560 |
| Data | 2013-10-04 |
| (87) | Numeris | WO 2014/055938 |
| Data | 2014-04-10 |
| (30) | Numeris | Data | Šalis |
| 201261709704 P | 2012-10-04 | US |
| (72) |
DEOKAR, Rhushikesh, Chandrabhan, IN
DUGAR, Sundeep, US
MAHAJAN, Dinesh, IN
WERNER, Milton, Henry, US
|
| (73) |
Sphaera Pharma Pte. Ltd,
8 Temasek Boulevard 22-03 Suntec Tower 3, Singapore 038988,
SG
Inhibikase Therapeutics, Inc., 3350 Riverwood Parkway Suite 1927, Atlanta, GA 30339, US |
| (54) | NOVEL COMPOUNDS, THEIR PREPARATION AND THEIR USES |
| NOVEL COMPOUNDS, THEIR PREPARATION AND THEIR USES |